600285.SHG Henan Lingrui Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
23.57 CNY
Close of Nov 5, 2026
18.51 23.83
Market cap
CNY 13.4B
P/E
16.1x
P/B
3.87x
ROE
27.7%
Dividend yield
3.83%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600285.SHG undervalued?

Graham number
Price23.57
Graham value14.15
Premium66.6%

600285.SHG trades 66.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Henan Lingrui Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Henan Lingrui Pharmaceutical Co Ltd yet.

Henan Lingrui Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Henan Lingrui Pharmaceutical Co Ltd

Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Medical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orthopedic, cardiovascular, cerebrovascular, dermatology, pediatrics, respiratory, nutritio…

Full company profile